Patent · US Active

Process for the preparation of Raltegravir

US11246869B2 · kind B2 · utility

0Cited by

4References

20Claims

0Family size

Assignee

CAMBREX PROFARMACO MILANO S.R.L. · IT

Inventors

Francesco Caputo · Paullo, IT
Daniele Vigo · Paullo, IT
Oreste Piccolo

Key dates

Filing date	Nov 13, 2018
Grant date	Feb 15, 2022
Priority date	—
Expiry date	Feb 11, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a process for the preparation of Raltegravir and pharmaceutically acceptable salts thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.